ECSP982468A - Derivados de nicotinamida - Google Patents

Derivados de nicotinamida

Info

Publication number
ECSP982468A
ECSP982468A ECSP982468A ECSP982468A EC SP982468 A ECSP982468 A EC SP982468A EC SP982468 A ECSP982468 A EC SP982468A EC SP982468 A ECSP982468 A EC SP982468A
Authority
EC
Ecuador
Prior art keywords
disease
respiratory
nicotinamide derivatives
allergic
inflammatory
Prior art date
Application number
Other languages
English (en)
Inventor
Anthony Marfat
Allen Jacob Duplantier
Robert James Chambers
John Wesley Watson
John Bin Cheng
Edward Fox Kleinman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982468 priority Critical patent/ECSP982468A/es
Publication of ECSP982468A publication Critical patent/ECSP982468A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invención se refiere a derivados de nicotinamida que son inhibidores selectivos de la fosfodiesterasa de tipo 4 (PDE4) y de la producción del factor de necrosis tumoral (TNF) y que, como tales, son útiles en el tratamiento de trastornos respiratorios, alérgicos, reumatoides, de regulación del peso corporal, inflamatorios y del sistema nervioso central, tales como asma, enfermedad obstructiva crónica pulmonar, síndrome de enfermedades respiratorias en adultos, shock, fibrosis, hipersensibilidad pulmonar, rinitis alérgica, dermatitis atópica, psoriasis, control de peso, artritis reumatoide, caquexia, enfermedad de Crohn, colitis ulcerosa, afecciones artriticas y otras enfermedades inflamatorias, depresión, demencia multi-infarto y SIDA.
ECSP982468 1998-04-02 1998-04-02 Derivados de nicotinamida ECSP982468A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982468 ECSP982468A (es) 1998-04-02 1998-04-02 Derivados de nicotinamida

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982468 ECSP982468A (es) 1998-04-02 1998-04-02 Derivados de nicotinamida

Publications (1)

Publication Number Publication Date
ECSP982468A true ECSP982468A (es) 1999-01-12

Family

ID=42043389

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982468 ECSP982468A (es) 1998-04-02 1998-04-02 Derivados de nicotinamida

Country Status (1)

Country Link
EC (1) ECSP982468A (es)

Similar Documents

Publication Publication Date Title
BR9810733A (pt) Derivados de nicotinamida
SV1999000120A (es) 1-aril-3-arilmetil-1,8-naftiridin-4 (1h)-onas ref. pc10020/82739/bb
WO2007114848A3 (en) Chemical compounds
NO20052076L (no) Fuserte azol-pyrimidinderivater.
TNSN07098A1 (en) 2,6- substituted -4- monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists
TW200610757A (en) New pyridazin-3(2H)-one derivatives
UA88472C2 (en) Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
GT199700075A (es) Analogos de indazol sustituido
WO2010120374A3 (en) Peptides targeting tnf family receptors and antagonizing tnf action, compositions, methods and uses thereof
GT199700102A (es) Derivados de indazol.
GEP20207104B (en) 2-phenyl-3-(piperazinomethyl)imidazo[1,2-a]pyridine derivatives as blockers of task-1 and task-2 channels, for the treatment of sleep-related breathing disorders
MX2018001851A (es) Metodos y composiciones que usan bifidobacterium longum para tratar o prevenir sintomas depresivos.
TNSN08131A1 (en) Dihydrogen phosphate salt of a prostaglandin d2 receptor antagonist
PL372466A1 (en) Carboxylic acid compounds and drugs containing the compounds as the active ingredient
MX2009003100A (es) Inhibidores de fosfodiesterasa tipo iv.
WO2007062318A3 (en) Chemical compounds
ECSP982468A (es) Derivados de nicotinamida
WO2005051931A3 (en) Phosphodiesterase inhibitors
ECSP993095A (es) 1-aril-3- arilmetil -8 -naftiridin -4 (1h)-(onas)
WO2017126700A9 (ja) 小胞型ヌクレオチドトランスポーター活性阻害剤
WO2005058898A3 (en) Purine compounds which can be used as phosphodiesterase (pde) type iv inhibitors
FI963882A0 (fi) Bentsotiatsolijohdannaiset 5-lipoksigenaasibiosynteesin estoaineina
Manni et al. PhosphoINOSitide-3 Kinase Inhibition In Th17-Dominant Allergic Airway Disease In Mice
WO2007046022A3 (en) Inhibitors of phosphodiesterase type-iv
MX9603943A (es) Compuestos de isoxazolina como inhibidores de 5-lipooxigenasa.